ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia
Abstract MLL-rearranged acute myeloid leukemia (AML) remains a fatal disease with a high rate of relapse and therapeutic failure due to chemotherapy resistance. In analysis of our Affymetrix microarray profiling and chromatin immunoprecipitation (ChIP) assays, we found that ALOX5 is especially down-...
Enregistré dans:
Auteurs principaux: | Yungui Wang, Jennifer R. Skibbe, Chao Hu, Lei Dong, Kyle Ferchen, Rui Su, Chenying Li, Hao Huang, Hengyou Weng, Huilin Huang, Xi Qin, Jie Jin, Jianjun Chen, Xi Jiang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f693c34a5ab845d5aef3a46dd809a2a8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
par: Yue Sheng, et autres
Publié: (2020) -
MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
par: Svetlana S. Itskovich, et autres
Publié: (2020) -
MiRNA-495 regulates proliferation and apoptosis of acute myeloid leukemia cells with MLL gene rearrangement by targeting STYX
par: YANG Rui, et autres
Publié: (2021) -
Publisher Correction: MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
par: Svetlana S. Itskovich, et autres
Publié: (2020) -
Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
par: Xi Jiang, et autres
Publié: (2017)